{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T03:48:03Z","timestamp":1784951283989,"version":"3.55.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Research Grant from the Greek Rheumatology Society and Professional Association of Rheumatologists"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Evidence on comorbidity prevalence in antiphospholipid syndrome (APS) and its difference from high comorbidity burden rheumatic diseases is limited. Herein, we compare multiple comorbidities between APS and RA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A total of 326 patients from the Greek APS registry [237 women, mean age 48.7\u2009(13.4)\u2009years, 161 primary APS (PAPS), 165 SLE-APS] were age\/sex matched (1:2 ratio) with 652 patients from a Greek multicentre RA cohort of 3115 patients. Prevalence of cardiovascular (CV) risk factors, stroke, coronary artery disease (CAD), osteoporosis, diabetes mellitus (DM), chronic obstructive pulmonary disease (COPD), depression and neoplasms were compared between APS and RA patients using multivariate regression analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>\u0397yperlipidemia and obesity (\u0392\u039c\u0399\u2009\u2265\u200930\u2009kg\/m2) were comparable while hypertension, smoking, stroke and CAD were more prevalent in APS compared with RA patients. Osteoporosis and depression were more frequent in APS, while DM, COPD and neoplasms did not differ between the two groups. Comparison of APS subgroups to 1:2 matched RA patients revealed that smoking and stroke were more prevalent in both PAPS and SLE-APS vs RA. Hypertension, CAD and osteoporosis were more frequent only in SLE-APS vs RA, whereas DM was less prevalent in PAPS vs RA. Hyperlipidaemia was independently associated with CV events (combined stroke and CAD) in PAPS and SLE-APS, while CS duration was associated with osteoporosis in SLE-APS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Comorbidity burden in APS (PAPS and SLE-APS) is comparable or higher than that in RA, entailing a high level of diligence for CV risk prevention, awareness for depression and CS exposure minimization.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa321","type":"journal-article","created":{"date-parts":[[2020,6,7]],"date-time":"2020-06-07T19:07:02Z","timestamp":1591556822000},"page":"170-178","source":"Crossref","is-referenced-by-count":31,"title":["Comparable or higher prevalence of comorbidities in antiphospholipid syndrome <i>vs<\/i> rheumatoid arthritis: a multicenter, case-control study"],"prefix":"10.1093","volume":"60","author":[{"given":"Stylianos","family":"Panopoulos","sequence":"first","affiliation":[{"name":"Joint Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Athens"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Thomas","sequence":"additional","affiliation":[{"name":"Joint Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Athens"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Georgiopoulos","sequence":"additional","affiliation":[{"name":"Joint Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Athens"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Boumpas","sequence":"additional","affiliation":[{"name":"Joint Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Athens"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Katsiari","sequence":"additional","affiliation":[{"name":"Medical School, University of Thessaly, Larissa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Bertsias","sequence":"additional","affiliation":[{"name":"Medical School, University of Crete, Heraklion"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2232-0326","authenticated-orcid":false,"given":"Alexandros A","family":"Drosos","sequence":"additional","affiliation":[{"name":"Medical School, University of Ioannina, Ioannina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyriaki","family":"Boki","sequence":"additional","affiliation":[{"name":"Sismanogleio General Hospital, Athens"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0364-1642","authenticated-orcid":false,"given":"Theodoros","family":"Dimitroulas","sequence":"additional","affiliation":[{"name":"Medical School, Aristotle University of Thessaloniki, Thessaloniki"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Garyfallos","sequence":"additional","affiliation":[{"name":"Medical School, Aristotle University of Thessaloniki, Thessaloniki"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6207-496X","authenticated-orcid":false,"given":"Charalampos","family":"Papagoras","sequence":"additional","affiliation":[{"name":"Medical School, University of Thrace, Alexandroupoli"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pelagia","family":"Katsimbri","sequence":"additional","affiliation":[{"name":"Joint Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Athens"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apostolos","family":"Tziortziotis","sequence":"additional","affiliation":[{"name":"Medical School, University of Thessaly, Larissa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Adamichou","sequence":"additional","affiliation":[{"name":"Medical School, University of Crete, Heraklion"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evripidis","family":"Kaltsonoudis","sequence":"additional","affiliation":[{"name":"Medical School, University of Ioannina, Ioannina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Argyriou","sequence":"additional","affiliation":[{"name":"Sismanogleio General Hospital, Athens"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Vosvotekas","sequence":"additional","affiliation":[{"name":"Private practice, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5484-2930","authenticated-orcid":false,"given":"Petros P","family":"Sfikakis","sequence":"additional","affiliation":[{"name":"Joint Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Athens"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Vassilopoulos","sequence":"additional","affiliation":[{"name":"Joint Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Athens"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G","family":"Tektonidou","sequence":"additional","affiliation":[{"name":"Joint Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Athens"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,6,29]]},"reference":[{"key":"2021010517022678100_keaa321-B1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/ar2669","article-title":"Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases","volume":"11","author":"Gabriel","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"2021010517022678100_keaa321-B2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"2021010517022678100_keaa321-B3","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.jacc.2017.02.058","article-title":"Antiphospholipid syndrome: role of vascular endothelial cells and implications for risk stratification and targeted therapeutics","volume":"69","author":"Corban","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2021010517022678100_keaa321-B4","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3389\/fimmu.2019.00764","article-title":"New biomarkers for atherothrombosis in antiphospholipid syndrome: genomics and epigenetics approaches","volume":"10","author":"Lopez-Pedrera","year":"2019","journal-title":"Front Immunol"},{"key":"2021010517022678100_keaa321-B5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/1744666X.2017.1327353","article-title":"The evolving concept of SLE comorbidities","volume":"13","author":"Gonz\u00e1lez","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"2021010517022678100_keaa321-B6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jbspin.2016.05.012","article-title":"Collection and management of selected comorbidities and their risk factors in chronic inflammatory rheumatic diseases in daily practice in France","volume":"83","author":"Gossec","year":"2016","journal-title":"Jt Bone Spine"},{"key":"2021010517022678100_keaa321-B7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13075-018-1771-0","article-title":"Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort study","volume":"20","author":"Panopoulos","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2021010517022678100_keaa321-B8","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/BOR.0000000000000267","article-title":"Comorbidities in rheumatoid arthritis","volume":"28","author":"Dougados","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"2021010517022678100_keaa321-B9","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of systemic lupus international","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2021010517022678100_keaa321-B10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"2021010517022678100_keaa321-B11","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3109\/07853890.2014.959559","article-title":"Markers of cardiovascular risk in patients with antiphospholipid syndrome: a meta-analysis of literature studies","volume":"46","author":"Ambrosino","year":"2014","journal-title":"Ann Med"},{"key":"2021010517022678100_keaa321-B12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.semarthrit.2007.08.002","article-title":"Early atheroma in primary and secondary antiphospholipid syndrome: an intrinsic finding","volume":"37","author":"Belizna","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"2021010517022678100_keaa321-B13","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.semarthrit.2017.10.015","article-title":"Carotid and femoral atherosclerosis in antiphospholipid syndrome: equivalent risk with diabetes mellitus in a case-control study","volume":"47","author":"Kravvariti","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"2021010517022678100_keaa321-B14","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3390\/jcm8071084","article-title":"Silent myocardial perfusion abnormalities detected by stress cardiovascular magnetic resonance in antiphospholipid syndrome: a case-control study","volume":"8","author":"Mavrogeni","year":"2019","journal-title":"J Clin Med"},{"key":"2021010517022678100_keaa321-B15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbrc.2019.03.020","article-title":"Anti-\u03b22GPI antibodies enhance atherosclerosis in ApoE-deficient mice","volume":"512","author":"Wang","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"2021010517022678100_keaa321-B16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1196\/annals.1361.073","article-title":"OxLDL\/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement","volume":"1051","author":"Lopez","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"2021010517022678100_keaa321-B17","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.5551\/jat.24372","article-title":"Involvement of TLR4 in oxidized LDL\/\u03b22GPI\/Anti-\u03b22GPI-induced transformation of macrophages to foam cells","volume":"21","author":"Zhang","year":"2014","journal-title":"J Atheroscler Thromb"},{"key":"2021010517022678100_keaa321-B18","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/ATVBAHA.113.302680","article-title":"Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on \u03b22GPI-specific T cell response","volume":"34","author":"Conti","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2021010517022678100_keaa321-B19","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/annrheumdis-2016-209442","article-title":"Endothelial progenitor dysfunction associates with a type I interferon signature in primary antiphospholipid syndrome","volume":"76","author":"Grenn","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021010517022678100_keaa321-B20","doi-asserted-by":"crossref","first-page":"102311","DOI":"10.1016\/j.jaut.2019.102311","article-title":"Type I interferon gene expression in antiphospholipid syndrome: pathogenetic, clinical and therapeutic implications","volume":"104","author":"Xourgia","year":"2019","journal-title":"J Autoimmun"},{"key":"2021010517022678100_keaa321-B21","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1136\/annrheumdis-2013-205159","article-title":"Cigarette smoking, antiphospholipid antibodies and vascular events in Systemic Lupus Erythematosus","volume":"74","author":"Gustafsson","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2021010517022678100_keaa321-B22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-016-8565-4","article-title":"Anti-phospholipid antibodies and smoking: an overview","volume":"53","author":"Binder","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"2021010517022678100_keaa321-B23","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1136\/ard.2010.142042","article-title":"Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study","volume":"70","author":"Ruffatti","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2021010517022678100_keaa321-B24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/art.24232","article-title":"Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies","volume":"61","author":"Tektonidou","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2021010517022678100_keaa321-B25","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients","volume":"74","author":"Cervera","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2021010517022678100_keaa321-B26","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1177\/0961203307081847","article-title":"Impact of hypertension and hyperhomocysteinemia on arterial thrombosis in primary antiphospholipid syndrome","volume":"16","author":"De Souza","year":"2007","journal-title":"Lupus"},{"key":"2021010517022678100_keaa321-B27","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1136\/annrheumdis-2013-204837","article-title":"Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2","volume":"74","author":"Carmona-Rivera","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2021010517022678100_keaa321-B28","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.4049\/jimmunol.1001782","article-title":"The detrimental effects of IFN-\u03b1 on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction","volume":"185","author":"Thacker","year":"2010","journal-title":"J Immunol"},{"key":"2021010517022678100_keaa321-B29","doi-asserted-by":"crossref","first-page":"e000508","DOI":"10.1136\/rmdopen-2017-000508","article-title":"Endothelial dysfunction is associated with activation of the type i interferon system and platelets in patients with systemic lupus erythematosus","volume":"3","author":"Tyd\u00e9n","year":"2017","journal-title":"RMD Open"},{"key":"2021010517022678100_keaa321-B30","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.autrev.2019.05.011","article-title":"The burden of chronic kidney disease in systemic lupus erythematosus: a nationwide epidemiologic study","volume":"18","author":"Mageau","year":"2019","journal-title":"Autoimmun Rev"},{"key":"2021010517022678100_keaa321-B31","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/art.39758","article-title":"Brief Report: trends in hospitalizations due to acute coronary syndromes and stroke in patients with systemic lupus erythematosus, 1996 to 2012","volume":"68","author":"Tektonidou","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2021010517022678100_keaa321-B32","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/rheumatology\/keh581","article-title":"Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome","volume":"44","author":"Jim\u00e9nez","year":"2005","journal-title":"Rheumatology"},{"key":"2021010517022678100_keaa321-B33","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2021010517022678100_keaa321-B34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12888-017-1234-1","article-title":"Prevalence of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis","volume":"17","author":"Zhang","year":"2017","journal-title":"BMC Psychiatry"},{"key":"2021010517022678100_keaa321-B35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.semarthrit.2019.06.017","article-title":"Prevalence and metric of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis","volume":"50","author":"Moustafa","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2021010517022678100_keaa321-B36","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1093\/rheumatology\/ket169","article-title":"The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis","volume":"52","author":"Matcham","year":"2013","journal-title":"Rheumatology"},{"key":"2021010517022678100_keaa321-B37","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3899\/jrheum.090781","article-title":"Chronic conditions and health problems in rheumatic diseases: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, systemic lupus erythematosus, and fibromyalgia","volume":"37","author":"Wolfe","year":"2010","journal-title":"J Rheumatol"},{"key":"2021010517022678100_keaa321-B38","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10067-014-2677-0","article-title":"Depression, anxiety, and quality of life in a large cohort of patients with rheumatic diseases: common, yet undertreated","volume":"35","author":"Anyfanti","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2021010517022678100_keaa321-B39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/acr.22992","article-title":"Depression and progression of subclinical cardiovascular disease in systemic lupus erythematosus","volume":"69","author":"Jorge","year":"2017","journal-title":"Arthritis Care Res"},{"key":"2021010517022678100_keaa321-B40","first-page":"1835","article-title":"Systemic lupus erythematosus and the antiphospholipid syndrome: reflections about the relevance of ARA criteria","volume":"19","author":"Piette","year":"1992","journal-title":"J Rheumatol"},{"key":"2021010517022678100_keaa321-B41","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.autrev.2018.03.011","article-title":"Classification of primary antiphospholipid syndrome as systemic lupus erythematosus: analysis of a cohort of 214 patients","volume":"17","author":"Paule","year":"2018","journal-title":"Autoimmun Rev"},{"key":"2021010517022678100_keaa321-B42","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2021010517022678100_keaa321-B43","doi-asserted-by":"crossref","first-page":"2235042X1882020","DOI":"10.1177\/2235042X18820209","article-title":"Chronic obstructive pulmonary disease and rheumatic diseases: a systematic review on a neglected comorbidity","volume":"9","author":"Gergianaki","year":"2019","journal-title":"J Comorbidity"},{"key":"2021010517022678100_keaa321-B44","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.autrev.2009.04.001","article-title":"Antiphospholipid antibodies and malignancies","volume":"9","author":"Tincani","year":"2010","journal-title":"Autoimmun Rev"},{"key":"2021010517022678100_keaa321-B45","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1161\/01.CIR.99.9.1165","article-title":"Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland","volume":"99","author":"Jousilahti","year":"1999","journal-title":"Circulation"},{"key":"2021010517022678100_keaa321-B46","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/eurheartj\/ehn018","article-title":"Risk factors for myocardial infarction in women and men: insights from the INTERHEART study","volume":"29","author":"Anand","year":"2008","journal-title":"Eur Heart J"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/1\/170\/35433727\/keaa321.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/1\/170\/35433727\/keaa321.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T09:23:04Z","timestamp":1610270584000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/1\/170\/5864536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,29]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,6,29]]},"published-print":{"date-parts":[[2021,1,5]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa321","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,1]]},"published":{"date-parts":[[2020,6,29]]}}}